Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Glossary Privacy Policy

New Indication for Weight Loss Drug Semaglutide. | Pepdox

Home
Search
PMID 37233137

New Indication for Weight Loss Drug Semaglutide.

The American journal of nursing2023PMID: 37233137

View on PubMed DOI: 10.1097/01.NAJ.0000938724.36679.23

Abstract

The weight loss drug semaglutide (Wegovy) is now approved for pediatric patients ages 12 and older whose body mass index categorizes them as obese.

Authors

Aschenbrenner, Diane S